Literature DB >> 16123742

Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function.

Neal R Swerdlow1, Alison S Krupin, Michele J Bongiovanni, Jody M Shoemaker, Jana C Goins, Ronald P Hammer.   

Abstract

We reported heritable differences between Sprague-Dawley (SD) and Long Evans (LE) rats in their sensitivity to the disruption of prepulse inhibition of startle (PPI) by dopamine (DA) agonists, and in their basal levels and turnover of forebrain DA. In an effort to better understand these differences, we assessed strain patterns in the efficacy of D2-like receptor-G-protein coupling using [35S]GTPgammaS binding in brain regions that contribute to the dopaminergic regulation of PPI. Sensitivity to the PPI-disruptive effects of apomorphine (APO) was examined in SD, LE, and F1 (SD x LE) rats. Basal and DA-stimulated [35S]GTPgammaS binding were then assessed in these rats using conditions that preferentially exclude Gs proteins to favor visualization of D2-like receptors. To explore the behavioral specificity of these strain differences, locomotor responses to APO and amphetamine (AMPH) were also assessed in SD, LE, and F1 rats. Strain differences were evident in the PPI-disruptive effects of APO (SD>F1>LE), and in the locomotor responses to AMPH (LE>F1>SD) and APO (SD exhibited motor suppression, LE exhibited motor activation). Compared to SD rats, LE rats exhibited greater DA-stimulated [35S]GTPgammaS binding in nucleus accumbens and caudatoputamen, while F1 progeny had intermediate levels. In conclusion, SD and LE rats exhibit heritable differences in D2-mediated behavioral and biochemical measures. Conceivably, genes that regulate heritable differences in forebrain D2 function may contribute to heritable differences in PPI in patients with specific neuropsychiatric disorders, including schizophrenia and Tourette Syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16123742      PMCID: PMC1403813          DOI: 10.1038/sj.npp.1300877

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  26 in total

Review 1.  Molecular effects of dopamine on striatal-projection pathways.

Authors:  C R Gerfen
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

2.  Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Leia Pitcher; Amanda Platten; Ronald Kuczenski; Catharine C Eleey; Pamela Auerbach
Journal:  Behav Neurosci       Date:  2002-08       Impact factor: 1.912

Review 3.  Network-level neuroplasticity in cortico-basal ganglia pathways.

Authors:  Ann M Graybiel
Journal:  Parkinsonism Relat Disord       Date:  2004-07       Impact factor: 4.891

Review 4.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

5.  Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.

Authors:  N R Swerdlow; Z A Martinez; F M Hanlon; A Platten; M Farid; P Auerbach; D L Braff; M A Geyer
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants.

Authors:  N R Swerdlow; A Platten; Y K Kim; I Gaudet; J Shoemaker; L Pitcher; P Auerbach
Journal:  Pharmacol Biochem Behav       Date:  2001 Oct-Nov       Impact factor: 3.533

7.  Recovery of sensorimotor gating without G protein adaptation after repeated D2-like dopamine receptor agonist treatment in rats.

Authors:  Kerry E Culm; Ronald P Hammer
Journal:  J Pharmacol Exp Ther       Date:  2003-10-30       Impact factor: 4.030

8.  Reduced G(i) and G(o) protein function in the rat nucleus accumbens attenuates sensorimotor gating deficits.

Authors:  Kerry E Culm; Antonio M Lim; Julie A Onton; Ronald P Hammer
Journal:  Brain Res       Date:  2003-08-22       Impact factor: 3.252

9.  Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Amanda Platten; Leia Pitcher; Jana Goins; Sarah Crain
Journal:  Pharmacol Biochem Behav       Date:  2003-04       Impact factor: 3.533

10.  Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Sarah Crain; Jana Goins; Kaori Onozuka; Pamela P Auerbach
Journal:  Pharmacol Biochem Behav       Date:  2004-02       Impact factor: 3.533

View more
  19 in total

1.  Reduced startle gating after D1 blockade: effects of concurrent D2 blockade.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2005-09-26       Impact factor: 3.533

2.  Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.

Authors:  Paul D Shilling; Richard L Saint Marie; Jody M Shoemaker; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2008-02-20       Impact factor: 13.382

3.  Probing the molecular basis for an inherited sensitivity to the startle-gating disruptive effects of apomorphine in rats.

Authors:  Neal R Swerdlow; Michelle R Breier; Richard L Saint Marie
Journal:  Psychopharmacology (Berl)       Date:  2011-03-02       Impact factor: 4.530

Review 4.  The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?

Authors:  Mark A Geyer
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats.

Authors:  Neal R Swerdlow; Paul D Shilling; Michelle Breier; Ryan S Trim; Gregory A Light; Richard Saint Marie
Journal:  Psychopharmacology (Berl)       Date:  2012-06-15       Impact factor: 4.530

6.  Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.

Authors:  Laura J Mosher; Roberto Frau; Alessandra Pardu; Romina Pes; Paola Devoto; Marco Bortolato
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

7.  Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

Review 8.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

9.  Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats.

Authors:  Michelle R Breier; Brittanni Lewis; Jody M Shoemaker; Gregory A Light; Neal R Swerdlow
Journal:  Behav Brain Res       Date:  2010-01-18       Impact factor: 3.332

10.  Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.

Authors:  Ying Qu; Richard L Saint Marie; Michelle R Breier; David Ko; David Stouffer; Loren H Parsons; Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2009-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.